Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

Six cycles of R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) are the standard treatment for aggressive B-cell non-Hodgkin lymphoma. In the FLYER trial, we assessed whether four cycles of CHOP plus six applications of rituximab are non-inferior to six cycles of R-C...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Poeschel, Viola [verfasserIn]

Held, Gerhard

Ziepert, Marita

Witzens-Harig, Mathias

Holte, Harald

Thurner, Lorenz

Borchmann, Peter

Viardot, Andreas

Soekler, Martin

Keller, Ulrich

Schmidt, Christian

Truemper, Lorenz

Mahlberg, Rolf

Marks, Reinhard

Hoeffkes, Heinz-Gert

Metzner, Bernd

Dierlamm, Judith

Frickhofen, Norbert

Haenel, Mathias

Neubauer, Andreas

Kneba, Michael

Merli, Francesco

Tucci, Alessandra

de Nully Brown, Peter

Federico, Massimo

Lengfelder, Eva

di Rocco, Alice

Trappe, Ralf

Rosenwald, Andreas

Berdel, Christian

Maisenhoelder, Martin

Shpilberg, Ofer

Amam, Josif

Christofyllakis, Konstantinos

Hartmann, Frank

Murawski, Niels

Stilgenbauer, Stephan

Nickelsen, Maike

Wulf, Gerald

Glass, Bertram

Schmitz, Norbert

Altmann, Bettina

Loeffler, Markus

Pfreundschuh, Michael

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2019

Umfang:

11

Übergeordnetes Werk:

Enthalten in: Effects of shape functions on flexural–torsional buckling of fixed circular arches - Dou, Chao ELSEVIER, 2013, London [u.a.]

Übergeordnetes Werk:

volume:394 ; year:2019 ; number:10216 ; day:21 ; month:12 ; pages:2271-2281 ; extent:11

Links:

Volltext

DOI / URN:

10.1016/S0140-6736(19)33008-9

Katalog-ID:

ELV048858234

Nicht das Richtige dabei?

Schreiben Sie uns!